Global interest in psychedelic substances increases by the day, and although clinical trials have yielded positive results, psychedelic research and clinical practice is in its infancy.  We find ourselves at a unique moment in time where increased access to information about psychedelics, even to the psychedelics themselves, is moving forward at a faster rate than the cultural and relational foundations can shift to accommodate this change in a safe, accessible, meaningful way. 

Alyssa Gursky and Rafael Lancelotta come on the Psychedologist to discuss the implications of this psychedelic "gold rush." We talk about how the vast and rapid growth of psychedelic businesses and therapies is not trauma informed.  We ponder questions such as, can psychedelics relieve the mental health crisis in the world, or is this an oversimplified pipe-dream, similar to the revolution SSRIs were expected to be? How does privilege come into play when it comes to psychedelic healing? Should we slow things down, rather than pressing forward to bring psychedelic therapies to the general population? Is there a more responsible, ethical, trauma informed model for rolling out psychedelic therapies than what is currently happening in the psychedelic landscape?

http://neilcic.com/

https://www.youtube.com/user/edbassmaster

https://www.marcrebillet.com/